Multimodal profiling of chordoma immunity reveals distinct immune contextures.

Journal Information

Full Title: J Immunother Cancer

Abbreviation: J Immunother Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Therapeutics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"the rna sequencing data generated in this study are publicly available on geo (gse239531). furthermore differential gene expression analysis revealed enrichment for other immune-related genes in chordomas in comparison with the other sarcomas ( online supplemental figure 1ab online supplemental table 4 ) 10 1136/jitc-2023-008138 supp2 supplementary data 10 1136/jitc-2023-008138 supp3 supplementary data to substantiate that immune-related processes are enriched in chordomas we evaluated the expression of genes included in the icr gene signature to compare between the distinct sarcoma subtypes. data availability statement data are available in a public open access repository. the rna sequencing data generated in this study are publicly available on geo (gse239531"

Code Sharing
Evidence found in paper:

"Competing interests: No, there are no competing interests."

Evidence found in paper:

"Funding: This work was financially supported by the intramural Leiden Center for Computational Oncology strategic fund. NFCCdM is funded by the European Research Council (ERC) under the European Union’s Horizon 2020 Research and Innovation Program (grant agreement no. 852832) and by the VIDI ZonMW (project number: 09150172110092). JVMGB is the recipient of a Cancer Research Institute/Chordoma Foundation CLIP Grant (CRI5106)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025